4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-018061
Chief Commercial Officer sold 13,934 shares at an average $20.63 ($287,435)
- Chief Commercial Officer acquired 15,137 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wettig Thane Chief Commercial Officer | 2023-03-08 | Sale | −6,265 | $21.16 | $132,542 | 104,090 | D: show line 1 in the form |
| Wettig Thane Chief Commercial Officer | 2023-03-08 | Grant or award | +5,799 | 109,889 | D: show line 2 in the form | ||
| Wettig Thane Chief Commercial Officer | 2023-03-08 | Grant or award | +9,338 | 119,227 | D: show line 3 in the form | ||
| Wettig Thane Chief Commercial Officer | 2023-03-10 | Sale | −2,938 | $20.20 | $59,340 | 116,289 | D: show line 4 in the form |
| Wettig Thane Chief Commercial Officer | 2023-03-10 | Sale | −4,731 | $20.20 | $95,553 | 111,558 | D: show line 5 in the form |
| Open-market sales · 13,934 sh · avg $20.63 · $287,435 | |||||||
Loading xslF345X03/doc4.xml…